Congestive Heart Failure Drugs Market Size Projected to Rise Lucratively during 2027

1. Congestive Heart Failure Drugs Market Size Congestive Heart Failure Drugs Market Size Projected to Rise Lucratively during 2027 Projected to Rise Lucratively during 2027 Congestive heart failure commonly called as heart failure is a medical condition that affects pumping ability of heart muscle. Certain medical conditions such as narrowing of arteries of the heart or high blood pressure gradually makes the heart too weak and stiff to fill and pump efficiently. Some symptoms of heart failure are shortness of breath while lying down or while exerting yourself, weakness, fatigue, swelling in legs, feet and ankles, irregular and rapid heartbeat, decrease in ability to exercise, persistent cough or wheezing with pink or white blood tinged phlegm, increased urination at night, swelling of abdomen, rapid weight gain due to fluid retention, lack of appetite, nausea, difficulty in concentrating, decreased alertness, severe shortness of breath and coughing up pink, and foamy mucus. There are four types of heart failure left-sided heart failure, right-sided heart failure, systolic heart failure and diastolic heart failure. Risk factors that can cause heart failure are high blood pressure, coronary artery disease, diabetes, sleep apnea, obesity, virus, alcohol use, hypertension and irregular heartbeat. Lifestyle changes can help in prevention of heart failure by reducing and managing stress, maintaining a healthy weight, eating healthy food, staying physically fit and active, controlling blood pressure, and diabetes. LIMITED TIME OFFER - Hurry Up! LIMITED TIME OFFER - Hurry Up! Get Discount For Buyers UPTO 30% OFF On Any Research Report Get Discount For Buyers UPTO 30% OFF On Any Research Report Apply Promo Code "CMIFIRST1000" And Get Instant Discount Of USD 1000 Apply Promo Code "CMIFIRST1000" And Get Instant Discount Of USD 1000 To Get Instant Access, Purchase Report Here @ To Get Instant Access, Purchase Report Here @ https://www.coherentmarketinsights.com/insight/ buy-now/1839 buy-now/1839 https://www.coherentmarketinsights.com/insight/ Congestive Heart Failure Drugs Market Drivers:- Congestive Heart Failure Drugs Market Drivers:-

2. Major driver for growth of the congestive heart failure drugs market is the robust pipeline of drugs under development. For instance, furosemide injection solution (SCP-101) sponsored by Johns Hopkins University in collaboration with Scpharmaceuticals Inc. was in phase 2 clinical trials in 2015, this injection is indicated for treatment of heart failure. Furosemide and Azosemide sponsored by Hyogo College of Medicine has completed phase 4 clinical trials in 2016, these drugs are used to treat congestive heart failure. Tolvaptan sponsored by Otsuka pharmaceuticals Co., Ltd was in phase 3 clinical trials in 2016, this drug is indicated for treatment of heart failure in children. Approval of new drugs from Food and Drug Administration (FDA) is also expected to fuel growth of the congestive heart failure drugs market. In 2016, FDA approved Byvalson by Allergan an Ireland-based company, this drug is used for treatment of hypertension. In 2015, FDA approved Corlanor (ivabradine) by Amgen Inc. a U.S.-based company, this drug treats chronic heart failure. Furthermore, increasing number of geriatric population, unhealthy lifestyle, and increasing awareness regarding treatment of chronic disorders are driving the congestive heart failure drugs market growth. Low awareness and diagnosis rate for the disease such as hypertension which is major cause of heart failure is primary restraint in global congestive heart failure drugs market. According to a study published in NCBI in 2013, only 49% of patients suffering from hypertension were aware of the diagnosis in high-income countries, and this percentage (i.e. 40.8%) was even lower in low-income countries. Congestive Heart Failure Drugs Market Regional Analysis:- Congestive Heart Failure Drugs Market Regional Analysis:- North America is expected to hold dominant position in congestive heart failure drugs market due to new product launches and mergers and acquisitions. For instance, in 2015, Amgen Inc. a U.S.-based company acquired Dezima Pharma, a Netherlands based company to expand its cardiovascular drug portfolio by adding cholesterol lowering drug TA-8995 to its portfolio. TA- 8995 is a cholesterol lowering drug. Moreover, Europe congestive heart failure drugs market is expected to witness significant growth due to launch of new drugs to treat chronic diseases, which prevent heart failures. For instance, Novartis AG launched a drug named Entresto in 2016, in UK. Entresto is used to treat heart failure with minimum ejection fraction (measurement of percentage of blood leaving heart each time it contracts), it is an angiotensin receptor-neprilysin inhibitor. Moreover, high prevalence of cardiovascular diseases in Asia Pacific is expected to support the growth of congestive heart failure drugs market in this

3. region. According to a study conducted by All India Institute of Medical Science (AIIMS) and Indian Council of Medical Research (ICMR) in 2016, India’s younger population i.e. below 30 years of age are at a higher risk of developing cardiovascular diseases due to unhealthy lifestyle, alcohol consumption, and tobacco consumption,. Congestive Heart Failure Drugs Market Key Players:- Congestive Heart Failure Drugs Market Key Players:- Key players operating in congestive heart failure drugs market include Amgen Inc, Novartis AG, Astra Zeneca Plc., Bayer AG, Gilead Sciences Inc, Glaxo Smith Kline, Pfizer Inc. and Teva Pharmaceutical Industries Ltd. Report includes chapters which deeply display the following deliverable about industry : Report includes chapters which deeply display the following deliverable about industry : • Congestive Heart Failure Drugs Market Research Objective and Assumption • Congestive Heart Failure Drugs Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Congestive Heart Failure Drugs Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Congestive Heart Failure Drugs Market, By Regions • Congestive Heart Failure Drugs Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Congestive Heart Failure Drugs Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Congestive Heart Failure Drugs Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Congestive Heart Failure Drugs Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region.

4. • Research Findings and Conclusion Request for Sample Copy: Request for Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/1839 https://www.coherentmarketinsights.com/insight/request-sample/1839 Congestive Heart Failure Drugs Market Taxonomy:- Congestive Heart Failure Drugs Market Taxonomy:- By Drug:- • ACE Inhibitors • Angiotensin 2 Receptor Blockers • Beta Blockers • Diuretics • Aldosterone antagonists • Inotropes • Others By Distribution Channel:- • Hospitals • Retail Pharmacies • Online Pharmacies By Region:- • North America • Europe • Latin America • Asia Pacific • Middle East • Africa About Coherent Market Insights About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive

5. analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Phone: US +12067016702 / UK +4402081334027 Email: Email: sales@coherentmarketinsights.com sales@coherentmarketinsights.com